These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 4036990

  • 1. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
    Meyer K, Williams EC.
    Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review.
    Sane DC, Pizzo SV, Greenberg CS.
    Am J Hematol; 1989 May; 31(1):53-7. PubMed ID: 2495717
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Congenital deficiency of the fibrinolysis inhibitor alpha 2-antiplasmin as a cause of hemorrhagic diathesis].
    Leebeek FW, Knot EA, Kluft C.
    Ned Tijdschr Geneeskd; 1988 Jan 23; 132(4):167-70. PubMed ID: 3277073
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acquired alpha-2 anti-plasmin deficiency secondary to amyloidosis.
    Clyne LP, Caldwell AB.
    Thromb Haemost; 1987 Aug 04; 58(2):797. PubMed ID: 3672434
    [No Abstract] [Full Text] [Related]

  • 10. Increased fibrinolysis and amyloidosis.
    Liebman H, Chinowsky M, Valdin J, Kenoyer G, Feinstein D.
    Arch Intern Med; 1983 Apr 04; 143(4):678-82. PubMed ID: 6340622
    [Abstract] [Full Text] [Related]

  • 11. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.
    Takahashi H, Koike T, Yoshida N, Kitahara O, Hanano M, Shibata A, Aoki N.
    Am J Hematol; 1986 Oct 04; 23(2):153-66. PubMed ID: 2944378
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL, Mathew P.
    Haemophilia; 2008 Nov 04; 14(6):1250-4. PubMed ID: 19141165
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Congenital alpha(2)-plasmin inhibitor deficiencies: a review.
    Favier R, Aoki N, de Moerloose P.
    Br J Haematol; 2001 Jul 04; 114(1):4-10. PubMed ID: 11472338
    [No Abstract] [Full Text] [Related]

  • 16. Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses.
    Bouma B, Maas C, Hazenberg BP, Lokhorst HM, Gebbink MF.
    J Thromb Haemost; 2007 Jun 04; 5(6):1139-42. PubMed ID: 17371485
    [No Abstract] [Full Text] [Related]

  • 17. [Congenital deficiency of alpha 2-plasmin inhibitor].
    Yoshinaga H, Hirosawa S.
    Ryoikibetsu Shokogun Shirizu; 1998 Jun 04; (21 Pt 2):488-90. PubMed ID: 9833551
    [No Abstract] [Full Text] [Related]

  • 18. Hemostasis associated with abnormalities of fibrinolysis.
    Aoki N.
    Blood Rev; 1989 Mar 04; 3(1):11-7. PubMed ID: 2650772
    [Abstract] [Full Text] [Related]

  • 19. Alpha 2-plasmin inhibitor and its deficiency states.
    Saito H.
    J Lab Clin Med; 1988 Dec 04; 112(6):671-8. PubMed ID: 3057093
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.